Ameritas Investment Partners’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $190K | Buy |
1,984
+241
| +14% | +$24.7K | 0.01% | 1419 |
|
|
2026
Q1 | $190K | Hold |
1,743
| – | – | 0.01% | 1290 |
|
|
2025
Q4 | $141K | Hold |
1,743
| – | – | ﹤0.01% | 1487 |
|
|
2025
Q3 | $153K | Sell |
1,743
-379
| -18% | -$33.8K | ﹤0.01% | 1408 |
|
|
2025
Q2 | $176K | Hold |
2,122
| – | – | 0.01% | 1376 |
|
|
2025
Q1 | $178K | Hold |
2,122
| – | – | 0.01% | 1330 |
|
|
2024
Q4 | $196K | Buy |
2,122
+160
| +8% | +$15.4K | 0.01% | 1338 |
|
|
2024
Q3 | $182K | Hold |
1,962
| – | – | 0.01% | 1383 |
|
|
2024
Q2 | $161K | Hold |
1,962
| – | – | 0.01% | 1412 |
|
|
2024
Q1 | $130K | Hold |
1,962
| – | – | ﹤0.01% | 1574 |
|
|
2023
Q4 | $111K | Hold |
1,962
| – | – | ﹤0.01% | 1659 |
|
|
2023
Q3 | $107K | Buy |
1,962
+331
| +20% | +$19.6K | ﹤0.01% | 1604 |
|
|
2023
Q2 | $110K | Buy |
1,631
+154
| +10% | +$9.39K | ﹤0.01% | 1533 |
|
|
2023
Q1 | $76K | Hold |
1,477
| – | – | ﹤0.01% | 1711 |
|
|
2022
Q4 | $70K | Hold |
1,477
| – | – | ﹤0.01% | 1831 |
|
|
2022
Q3 | $74K | Hold |
1,477
| – | – | ﹤0.01% | 1708 |
|
|
2022
Q2 | $67K | Hold |
1,477
| – | – | ﹤0.01% | 1796 |
|
|
2022
Q1 | $69K | Hold |
1,477
| – | – | ﹤0.01% | 1875 |
|
|
2021
Q4 | $74K | Hold |
1,477
| – | – | ﹤0.01% | 1872 |
|
|
2021
Q3 | $78K | Buy |
1,477
+175
| +13% | +$9.86K | ﹤0.01% | 1847 |
|
|
2021
Q2 | $79K | Hold |
1,302
| – | – | ﹤0.01% | 1873 |
|
|
2021
Q1 | $64K | Hold |
1,302
| – | – | ﹤0.01% | 1932 |
|
|
2020
Q4 | $53K | Hold |
1,302
| – | – | ﹤0.01% | 1956 |
|
|
2020
Q3 | $42K | Hold |
1,302
| – | – | ﹤0.01% | 1941 |
|
|
2020
Q2 | $34K | Hold |
1,302
| – | – | ﹤0.01% | 2065 |
|
|
2020
Q1 | $32K | Hold |
1,302
| – | – | ﹤0.01% | 1910 |
|
|
2019
Q4 | $47K | Hold |
1,302
| – | – | ﹤0.01% | 1958 |
|
|
2019
Q3 | $45K | Hold |
1,302
| – | – | ﹤0.01% | 1945 |
|
|
2019
Q2 | $36K | Hold |
1,302
| – | – | ﹤0.01% | 2104 |
|
|
2019
Q1 | $40K | Hold |
1,302
| – | – | ﹤0.01% | 2014 |
|
|
2018
Q4 | $31K | Hold |
1,302
| – | – | ﹤0.01% | 2069 |
|
|
2018
Q3 | $50K | Hold |
1,302
| – | – | ﹤0.01% | 1996 |
|
|
2018
Q2 | $44K | Hold |
1,302
| – | – | ﹤0.01% | 2072 |
|
|
2018
Q1 | $47K | Hold |
1,302
| – | – | ﹤0.01% | 1955 |
|
|
2017
Q4 | $41K | Hold |
1,302
| – | – | ﹤0.01% | 2032 |
|
|
2017
Q3 | $47K | Hold |
1,302
| – | – | ﹤0.01% | 1933 |
|
|
2017
Q2 | $41K | Buy |
1,302
+385
| +42% | +$11.1K | ﹤0.01% | 2041 |
|
|
2017
Q1 | $23K | Buy |
+917
| New | +$21.5K | ﹤0.01% | 2327 |
|
Other funds holding LMAT
CCA
CAM
CCM
Ameritas Investment Partners's LMAT Position: Q2 2026 in Review
Ameritas Investment Partners increased its LeMaitre Vascular (LMAT) stake by 14% in Q2 2026, buying an estimated $24.7K and bringing the position to 1,984 shares worth $190K. The position accounts for 0.01% of the portfolio, ranked #1419.
Ameritas Investment Partners first reported a position in LMAT in Q1 2017 and has held it in 38 quarters since. The position peaked at $196K in Q4 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Ameritas Investment Partners held 1,984 shares of LeMaitre Vascular worth $190K as of Q2 2026.
- Ameritas Investment Partners bought 241 LeMaitre Vascular shares in Q2 2026, an estimated $24.7K.
- LeMaitre Vascular made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1419 holding.
- Ameritas Investment Partners first reported a position in LeMaitre Vascular in Q1 2017 and has held it in 38 quarters since.
- Ameritas Investment Partners's LeMaitre Vascular position peaked at $196K in Q4 2024.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.